Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | (Q1)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 15.04%17.41B | 12.86%4.19B | 15.52%4.63B | 16.77%4.34B | 14.97%4.25B | 12.89%15.13B | 16.27%3.71B | 12.87%4.01B | 10.76%3.72B | 11.82%3.7B |
| Cost of revenue | 12.11%14.67B | 7.35%3.52B | 13.11%3.87B | 13.67%3.64B | 14.36%3.65B | 16.74%13.09B | 21.00%3.28B | 17.02%3.42B | 14.47%3.2B | 14.58%3.19B |
| Gross profit | 33.89%2.73B | 55.12%667M | 29.27%764M | 36.59%698M | 18.63%605M | -6.84%2.04B | -10.79%430M | -6.04%591M | -8.26%511M | -2.67%510M |
| Operating expense | 8.13%1.72B | 26.42%488M | 8.67%426M | 2.06%396M | -3.57%405M | 2.65%1.59B | -3.50%386M | 0.00%392M | 3.19%388M | 11.41%420M |
| Selling and administrative expenses | 8.13%1.72B | 26.42%488M | 8.67%426M | 2.06%396M | -3.57%405M | 2.65%1.59B | -3.50%386M | 0.00%392M | 3.19%388M | 11.41%420M |
| -Selling and marketing expense | 0.56%537M | 7.32%132M | -0.72%138M | -0.73%136M | -2.96%131M | 4.50%534M | 0.82%123M | 5.30%139M | 3.01%137M | 8.87%135M |
| -General and administrative expense | 11.98%1.18B | 35.36%356M | 13.83%288M | 3.59%260M | -3.86%274M | 1.74%1.05B | -5.40%263M | -2.69%253M | 3.29%251M | 12.65%285M |
| Operating profit | 123.46%1.02B | 306.82%179M | 69.85%338M | 145.53%302M | 122.22%200M | -29.52%456M | -46.34%44M | -16.03%199M | -32.04%123M | -38.78%90M |
| Net non-operating interest income (expenses) | 14.29%32M | 28.57%9M | 0.00%8M | 14.29%8M | 16.67%7M | 7.69%28M | 0.00%7M | 33.33%8M | 0.00%7M | 0.00%6M |
| Non-operating interest income | 14.29%32M | 28.57%9M | 0.00%8M | 14.29%8M | 16.67%7M | 7.69%28M | 0.00%7M | 33.33%8M | 0.00%7M | 0.00%6M |
| Non-operating interest expense | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Net investment income | 2,725.81%876M | 587.50%110M | -3.85%25M | 37.50%-10M | 14,920.00%751M | 181.82%31M | 366.67%16M | 188.89%26M | -420.00%-16M | 66.67%5M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | 0.00%35M | 12.50%9M | -10.00%9M | -11.11%8M | 12.50%9M | 0.00%35M | 0.00%8M | 0.00%10M | 12.50%9M | -11.11%8M |
| Special income (charges) | 87.50%-2M | 0 | -2M | -16M | -16M | |||||
| Less:Other special charges | -87.50%2M | --0 | ---- | ---- | ---- | --16M | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | 700.00%8M | -47.37%-28M | 50.00%27M | 700.00%8M | 0.00%1M | -66.67%1M | -575.00%-19M | 280.00%18M | -50.00%1M | -85.71%1M |
| Income before tax | 267.85%1.97B | 580.49%279M | 55.17%405M | 159.84%317M | 771.17%967M | -25.90%535M | -56.84%41M | 3.57%261M | -39.60%122M | -35.84%111M |
| Income tax | 498.68%455M | 186.36%57M | 55.70%123M | 187.88%95M | 500.00%180M | -63.46%76M | -400.00%-66M | 5.33%79M | -45.90%33M | -40.00%30M |
| Net income | 229.63%1.51B | 108.41%223M | 54.10%282M | 149.44%222M | 882.50%786M | -10.70%459M | 46.58%107M | 3.39%183M | -37.32%89M | -34.43%80M |
| Net income continuous operations | 229.63%1.51B | 107.48%222M | 54.95%282M | 149.44%222M | 871.60%787M | -10.70%459M | 46.58%107M | 2.82%182M | -36.88%89M | -34.15%81M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 229.63%1.51B | 108.41%223M | 54.10%282M | 149.44%222M | 882.50%786M | -10.70%459M | 46.58%107M | 3.39%183M | -37.32%89M | -34.43%80M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 229.63%1.51B | 108.41%223M | 54.10%282M | 149.44%222M | 882.50%786M | -10.70%459M | 46.58%107M | 3.39%183M | -37.32%89M | -34.43%80M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 229.63%216.14M | 108.41%31.86M | 54.10%40.29M | 149.44%31.71M | 882.50%112.29M | -10.70%65.57M | 46.58%15.29M | 3.39%26.14M | -37.32%12.71M | -34.43%11.43M |
| Diluted earnings per share | 229.63%216.14M | 108.41%31.86M | 54.10%40.29M | 149.44%31.71M | 882.50%112.29M | -10.70%65.57M | 46.58%15.29M | 3.39%26.14M | -37.32%12.71M | -34.43%11.43M |
| Dividend per share | 0.00%27.26M | -50.00%13.63M | 0 | 13.63M | 0 | 0.00%27.26M | 0.00%27.26M | 0 | 0 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |